Company Overview

ABEONA THERAPEUTICS INC.

ABEO
Revenue vs. Cost of Revenue
Revenue Cost of Revenue
Total Operating Expenses vs. Operating Income
Total Operating Expenses Operating Income
Net Income
Net Income
Revenue
6M
2025 FY
Net Income
71M
2025 FY
Shares Outstanding
53M
2025 FY
EPS
1.34USD
2025 FY
Company Information
SIC Code
2834
CIK Code
318306
Exchange
Nasdaq
Location
US